Comparative effectiveness of different methods of prescribing rosuvastatin and ezetimibe in combination with PCSK9 inhibitors
In: Медицинский вестник Юга России, Jg. 15 (2024), Heft 2, S. 81-89
Online
academicJournal
Zugriff:
Objective: comparative evaluation of the effectiveness of combined lipid-lowering therapy with rosuvastatin and ezetimibe in fixed and separate combinations with PCSK9 inhibitors in patients with very high cardiovascular risk.Materials and methods: 65 study participants were divided into 2 groups depending on the method of combined lipid-lowering therapy and were observed for 5 months on 6 visits. The effectiveness of the hypolipidemic response in each of the studied groups was evaluated.Results: in the group with separate administration of lipid-lowering drugs, the target values of LDL cholesterol reached 50% of patients, the level of LDL cholesterol during 5 months of treatment decreased by 38.22% from 2.25 [1.82; 2.47] mmol/l to 1.39 [1.21; 1.59] mmol/l (p
Titel: |
Comparative effectiveness of different methods of prescribing rosuvastatin and ezetimibe in combination with PCSK9 inhibitors
|
---|---|
Autor/in / Beteiligte Person: | Kuznetsov, A. A. ; Mal, G. S. ; Saraev, I. A. |
Link: | |
Zeitschrift: | Медицинский вестник Юга России, Jg. 15 (2024), Heft 2, S. 81-89 |
Veröffentlichung: | State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation, 2024 |
Medientyp: | academicJournal |
ISSN: | 2219-8075 (print) ; 2618-7876 (print) |
DOI: | 10.21886/2219-8075-2024-15-2-81-89 |
Schlagwort: |
|
Sonstiges: |
|